BenevolentAI logo

BenevolentAI

AI-driven drug discovery company identifying novel targets and therapies for complex diseases

London, United Kingdom Founded 2013 201-500 employees SaaS
Visit website

About BenevolentAI

BenevolentAI applies artificial intelligence and scientific expertise to drug discovery and life sciences decision-making. Its work has included building biomedical knowledge technology and using machine learning to help researchers investigate relationships among diseases, genes, biological processes, and potential treatments. The company has developed AI-enabled research capabilities for target identification, drug discovery, and analysis of scientific evidence, as well as collaborations with biopharmaceutical organizations. Its current website also presents Qor, a strategic intelligence offering for biopharma decision-makers and life sciences consultancies, drawing on its knowledge graph and proprietary ontologies. BenevolentAI serves pharmaceutical, biotechnology, and research organizations seeking AI drug discovery and scientific intelligence tools. By connecting biomedical data with machine learning and domain expertise, its platform and services support evidence-led research, therapeutic development, and strategic decisions across life sciences.

AI Tools & Services

No AI tools listed yet.

Reviews

No reviews yet.

Similar AI Companies